Seizert Capital Partners LLC Buys Shares of 30,825 AdaptHealth Corp. (NASDAQ:AHCO)

Key Points

• Seizert Capital Partners LLC has made a new investment in AdaptHealth Corp. (NASDAQ:AHCO), purchasing 30,825 shares worth approximately $334,000.
• Institutional investors hold a significant stake in AdaptHealth, with over 82.67% of the company's stock owned by various hedge funds and institutional investors.
• Research analysts have recently lowered their price targets for AdaptHealth shares, with an average rating of "Buy" and a consensus price target of $13.40.

Seizert Capital Partners LLC acquired a new stake in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 30,825 shares of the company's stock, valued at approximately $334,000.

Other institutional investors also recently modified their holdings of the company. SummerHaven Investment Management LLC boosted its stake in AdaptHealth by 1.7% during the first quarter. SummerHaven Investment Management LLC now owns 79,883 shares of the company's stock worth $866,000 after acquiring an additional 1,329 shares in the last quarter. Guggenheim Capital LLC boosted its stake in AdaptHealth by 10.1% during the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after acquiring an additional 1,525 shares in the last quarter. Sterling Capital Management LLC boosted its stake in AdaptHealth by 5.2% during the fourth quarter. Sterling Capital Management LLC now owns 33,558 shares of the company's stock worth $319,000 after acquiring an additional 1,644 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in AdaptHealth by 3.6% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 57,931 shares of the company's stock worth $552,000 after acquiring an additional 1,999 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. boosted its stake in AdaptHealth by 6.8% during the first quarter. Oppenheimer Asset Management Inc. now owns 32,797 shares of the company's stock worth $356,000 after acquiring an additional 2,081 shares in the last quarter. 82.67% of the stock is owned by institutional investors.

AdaptHealth Price Performance

Shares of AHCO stock traded down $0.22 during trading hours on Friday, reaching $8.75. The stock had a trading volume of 1,238,704 shares, compared to its average volume of 971,071. The stock's fifty day simple moving average is $9.04 and its 200 day simple moving average is $9.35. The company has a current ratio of 1.29, a quick ratio of 1.07 and a debt-to-equity ratio of 1.25. AdaptHealth Corp. has a 12 month low of $7.11 and a 12 month high of $11.70. The firm has a market capitalization of $1.18 billion, a PE ratio of 15.35, a PEG ratio of 0.86 and a beta of 1.58.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Royal Bank Of Canada lowered their price objective on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a report on Thursday, May 8th. Truist Financial decreased their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a report on Monday, May 12th. Five analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has an average rating of "Buy" and an average target price of $13.40.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.